Hubei Biocause Pharmaceutical Co., Ltd. approved final cash dividend per 10 A shares (tax included) of CNY 1.10000000 for the year 2022 at its AGM held on 19 May 2023. Record date is 29 May 2023; Ex-date is 30 May 2023; Payment date is 30 May 2023. Net cash dividend/10 shares after tax: CNY 0.99000000 (CNY 1.10000000 - CNY 0.11000000).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 CNY | -2.76% |
|
-7.85% | -38.03% |
06-17 | Biocause Pharma Plans Buyback of Up to 100 Million Yuan Shares | MT |
04-29 | Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.03% | 1.23B | |
+2.98% | 72.08B | |
+8.07% | 50.7B | |
+7.15% | 50.62B | |
+23.94% | 46.35B | |
+13.13% | 42.23B | |
+21.96% | 38.52B | |
+17.37% | 33.16B | |
-2.49% | 28.19B | |
+29.18% | 26.77B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 30 May 2023